The Official Journal of EuroPCR and the European Association of Percutaneous Coronary Interventions (EAPCI)

Topic review – TAVI and aortic regurgitation

Prognostic impact of aortic regurgitation after transcatheter aortic valve implantation

EuroIntervention 2012;8:Q31-Q33. DOI: 10.4244/EIJV8SQA7

Hasan Jilaihawi
Hasan Jilaihawi, MD, MRCP; Raj R. Makkar*, MD, FACC
Cedars-Sinai Heart Institute, Los Angeles, CA, USA

Aortic regurgitation (AR) is an important predictor of adverse prognosis after transcatheter aortic valve implantation (TAVI) by both self-expanding and balloon-expandable prostheses and is predominantly paravalvular (PV). Th

Sign in to read and download the full article

Forgot your password?
No account yet? Sign up for free!
Create my pcr account

Join us for free and access thousands of articles from EuroIntervention, as well as presentations, videos, cases from PCRonline.com

Share on Facebook Share on Twitter Share on Linkedin

Read next article

Treatment and prevention of aortic regurgitation after transcatheter aortic valve implantation

Latest news

NEW ISSUE
Atherectomies, in-stent restenosis, stent thrombosis, coronary physiology in TAVI and heart failure
July 17, 2020
NEW
Ahead of print: New technique of percutaneous mitral valvuloplasty
C. Aurigemma et al
July 29, 2020
Editorial
Rotational atherectomy and the myth of Sisyphus
Antonio Serra
July 29, 2020
Guidance Papers
Guidelines, consensus & position papers
June 25, 2020
Find the latest trials:
TICAKOREA, PEPCAD NSTEMI, CROSS-AMI, PARTNER-2A 5 years, and more
July 1, 2020
Editorial
Fractional flow reserve substitutes in aortic stenosis
Nils P. Johnson
July 29, 2020
JAA
This Week's JAA's: Coronary Artery Thrombosis, Maveric Trial...
July 28, 2020
Coronary
Valvular disease
Heart failure
Peripheral
Hypertension
Stroke